PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
Austin Kulasekararaj,
Francesco Lanza,
Alexandros Arvanitakis,
Saskia Langemeijer,
Satheesh Chonat,
Jia Cao,
Vincent Chow,
Haby Henary
Affiliations
Austin Kulasekararaj
1 King’s College Hospital NHS Foundation Trust, National Institute of Health Research/Wellcome King’s Clinical Research Facility and King’s College London, London, United Kingdom
Francesco Lanza
2 Azienda USL della Romagna, Ravenna, Italy
Alexandros Arvanitakis
3 Skånes Universitetssjukhus Malmö, Malmo, Sweden
Saskia Langemeijer
4 Radboud Universitair Medisch Centrum, Nijmegen, Gelderland, Holland, The Netherlands
Satheesh Chonat
5 Emory University and Children’s Healthcare of Atlanta, Department of Pediatrics, Atlanta, United States
